Growth Metrics

Gilead Sciences (GILD) FCF Payout Ratio (QoQ) (2015 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 34.59%
Dec 31, 2025 26.75%
Sep 30, 2025 -81.86%
Jun 30, 2025 127.98%
Mar 31, 2025 76.53%
Dec 31, 2024 46.78%
Sep 30, 2024 -71.36%
Jun 30, 2024 76.54%
Mar 31, 2024 -4.15%
Dec 31, 2023 -17.13%
Sep 30, 2023 34.52%
Jun 30, 2023 -26.80%
Mar 31, 2023 51.89%
Dec 31, 2022 13.17%
Sep 30, 2022 -38.63%
Jun 30, 2022 -3.98%
Mar 31, 2022 99.54%
Dec 31, 2021 0.89%
Sep 30, 2021 -29.29%
Jun 30, 2021 9.59%
Mar 31, 2021 -25.46%
Dec 31, 2020 21.73%
Sep 30, 2020 15.66%
Jun 30, 2020 -48.27%
Mar 31, 2020 103.25%
Dec 31, 2019 2.99%
Sep 30, 2019 -12.11%
Jun 30, 2019 -38.18%
Mar 31, 2019 73.08%
Dec 31, 2018 -3.79%
Sep 30, 2018 -37.69%
Jun 30, 2018 60.21%
Mar 31, 2018 35.71%
Dec 31, 2017 1.26%
Sep 30, 2017 33.06%
Jun 30, 2017 -18.35%
Mar 31, 2017 33.25%
Dec 31, 2016 23.68%
Sep 30, 2016 13.42%
Jun 30, 2016 -11.83%
Mar 31, 2016 36.14%
Dec 31, 2015 -34.14%
Sep 30, 2015 42.21%